Fig. 4: Association between overall survival in classic giant cell glioblastomas and glioblastomas with giant cell features based on molecular features.
From: SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma
Kaplan–Meier curves and log rank tests demonstrate that there is not significant difference in overall survival based on A ATRX status (p = 0.08) or B SMARCAL1 status (p = 0.09); however, C there was a significantly better overall survival in patients with ALT-positive tumors compared to patients with ALT-negative tumors (p < 0.03).
